Image of the Day: Tiny Targets

Beads filled with bacterial colonies indicate which antimicrobial compounds are working.

| 1 min read
micro alginate beads antibiotics antimicrobial resistance lantibiotic

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

ABOVE: A MICRO-ALGINATE BEAD CONTAINING A COLONY OF “LANTIBIOTIC”-PRODUCING CELLS (RED) HAS FEWER TARGET CELLS (GREEN) THAN SURROUNDING BEADS, INDICATING THAT THE SYNTHESIZED ANTIBIOTIC FROM THE PRODUCER CELLS IS WORKING.
STEVEN SCHMITT/ETH Zürich

Antimicrobial resistance is a currently one the biggest challenges in research and medicine. Researchers at ETH Zürich and the University of Regensburg have developed high-throughput methods for creating new lantibiotics. These are a class of antimicrobial peptides that can be synthesized in a laboratory setting. The research group engineered bacteria cells to produce different lantibiotics. These producer cells grew in single colonies alongside other bacteria within a micro-alginate bead made from a hydrogel. If the producer cells made lantibiotics with high antimicrobial activity, there were decreased numbers of the target cell colonies within that bead.

S. Schmitt et al., “Analysis of modular bioengineered antimicrobial lanthipeptides at nanoliter scale,” Nature Chemical Biology, doi:10.1038/s41589-019-0250-5, 2019.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Chia-Yi Hou

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio